EARLY ADMINISTRATION OF CYTOKINES AFTER RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES REDUCES DURATION OF APLASIA, HOSPITAL STAY AND TREATMENT-RELATED MORTALITY

Citation
S. Martinalgarra et al., EARLY ADMINISTRATION OF CYTOKINES AFTER RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES REDUCES DURATION OF APLASIA, HOSPITAL STAY AND TREATMENT-RELATED MORTALITY, Blood, 84(10), 1994, pp. 10000093-10000093
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000093 - 10000093
Database
ISI
SICI code
0006-4971(1994)84:10<10000093:EAOCAR>2.0.ZU;2-T